Literature DB >> 7304674

Benign Duchenne muscular dystrophy in a patient with growth hormone deficiency.

M Zatz, R T Betti, J A Levy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7304674     DOI： 10.1002/ajmg.1320100313

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN： 0148-7299


× No keyword cloud information.
  12 in total

Review 1.  Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.

Authors:  Joe N Kornegay; Janet R Bogan; Daniel J Bogan; Martin K Childers; Juan Li; Peter Nghiem; David A Detwiler; C Aaron Larsen; Robert W Grange; Ratna K Bhavaraju-Sanka; Sandra Tou; Bruce P Keene; James F Howard; Jiahui Wang; Zheng Fan; Scott J Schatzberg; Martin A Styner; Kevin M Flanigan; Xiao Xiao; Eric P Hoffman
Journal:  Mamm Genome       Date:  2012-01-05       Impact factor: 2.957

Review 2.  Mechanisms of resistance to pathogenesis in muscular dystrophies.

Authors:  J P Infante; V A Huszagh
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

Review 3.  Genetic modifiers of Duchenne and facioscapulohumeral muscular dystrophies.

Authors:  Rylie M Hightower; Matthew S Alexander
Journal:  Muscle Nerve       Date:  2017-09-22       Impact factor: 3.217

4.  Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy.

Authors:  S Hodgson; K Hart; S Abbs; J Heckmatt; E Rodillo; M Bobrow; V Dubowitz
Journal:  J Med Genet       Date:  1989-11       Impact factor: 6.318

Review 5.  On the nature of the Duchenne muscular dystrophy locus: a portion of a complex of related gene clusters of recent pseudoautosomal origin?

Authors:  J P Infante; V A Huszagh
Journal:  Mol Cell Biochem       Date:  1988-06       Impact factor: 3.396

6.  Becker and limb-girdle muscular dystrophy associated with pituitary dwarfism.

Authors:  G Marconi; R Taiuti; C Sbrilli; A Pizzi
Journal:  J Neurol       Date:  1987-08       Impact factor: 4.849

7.  Growth hormone evaluation in Duchenne muscular dystrophy.

Authors:  L Merlini; C Granata; A Ballestrazzi; F Cornelio; P Tassoni; S Tugnoli; E Cacciari
Journal:  Ital J Neurol Sci       Date:  1988-10

Review 8.  Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy.

Authors:  David G Allen; Nicholas P Whitehead; Stanley C Froehner
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

9.  Growth hormone inhibition causes increased selenium levels in Duchenne muscular dystrophy: a possible new approach to therapy.

Authors:  P J Collipp; J Kelemen; S Y Chen; M Castro-Magana; M Angulo; A Derenoncourt
Journal:  J Med Genet       Date:  1984-08       Impact factor: 6.318

10.  Serum cholinesterases are differentially regulated in normal and dystrophin-deficient mutant mice.

Authors:  Andrea R Durrant; Liliya Tamayev; Lili Anglister
Journal:  Front Mol Neurosci       Date:  2012-06-19       Impact factor: 5.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.